Indirubin promotes adipocyte differentiation and reduces lipid accumulation in 3T3‑L1 cells via peroxisome proliferator‑activated receptor γ activation

Konno,Taisuke; Sasaki,Kenroh; Kobayashi,Kyoko; Murata,Toshihiro

doi:10.3892/mmr.2020.10946

Indirubin promotes adipocyte differentiation and reduces lipid accumulation in 3T3‑L1 cells via peroxisome proliferator‑activated receptor γ activation

Authors:
- Taisuke Konno
- Kenroh Sasaki
- Kyoko Kobayashi
- Toshihiro Murata
View Affiliations

Affiliations: Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 981‑8558, Japan
Published online on: January 16, 2020 https://doi.org/10.3892/mmr.2020.10946
Pages: 1552-1560
Copyright: © Konno et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The peroxisome proliferator‑activated receptor γ (PPARγ) plays an important role in insulin sensitivity and adipocyte differentiation. It is known as ligand‑receptor that improves insulin sensitivity in type 2 diabetes mellitus. Several kinds of indigo plant have been already used to treat diabetes in oriental traditional medicine, but its mechanism has not been clarified yet. To investigate the effect of indirubin, which is a component of Polygonum tinctorium on the cell differentiation and adipprocess in 3T3‑L1 cells, 3T3‑L1 cells were cultured to determine the effect of cell differentiation and glucose uptake with indirubin. As a result, Indirubin compound enhanced adipocyte differentiation in 3T3‑L1 cells similar to rosiglitazone. This effect was terminated by cotreatment with GW9662, a PPARγ antagonist. In mature 3T3‑L1 adipocytes, the lipid droplet size and accumulation were reduced by this compound. The basal and insulin‑stimulated glucose uptakes were also significantly increased. In addition, indirubin treatment significantly enhanced estrogen level by 1.64‑fold with mature adipocytes which can be attributed to its aromatase activity. Conclutionaly, this finding suggested that indirubin is a potential anti‑diabetic compound for type 2 diabetes mellitus by promoting adipocyte differentiation and glucose uptake via PPARγ.

View Figures

View References

1	Lanktree MB and Hegele RA: Metabolic syndrome. Genomic Precis Med Prim Care Third Ed. 365:283–299. 2017. View Article : Google Scholar
2	Reuter S and Mrowka R: Obesity, adipocytes and insulin resistance-friends for life? Acta Physiol(Oxl). 225:e132582019.
3	Rosen ED and MacDougald OA: Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol. 7:885–896. 2006. View Article : Google Scholar : PubMed/NCBI
4	Lehrke M and Lazar MA: The many faces of PPARγ. Cell. 123:993–999. 2005. View Article : Google Scholar : PubMed/NCBI
5	Siersbæk R, Nielsen R and Mandrup S: PPARγ in adipocyte differentiation and metabolism-Novel insights from genome-wide studies. FEBS Lett. 584:3242–3249. 2010. View Article : Google Scholar : PubMed/NCBI
6	Schoonjans K, Staels B and Auwerx J: The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta. 1302:93–109. 1996. View Article : Google Scholar : PubMed/NCBI
7	Peters JM, Latruffe N, Passilly P, Motojima K and Gonzalez FJ: Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue- and inducer-specific manner. J Biol Chem. 273:16710–16714. 2002.
8	Cariou B, Charbonnel B and Staels B: Thiazolidinediones and PPARγ agonists: Time for a reassessment. Trends Endocrinol Metab. 23:205–215. 2012. View Article : Google Scholar : PubMed/NCBI
9	Masakia N, Fukudaa S, Ikeda M and Kurimoto M: Improvement of high fat diet-induced hyperlipidemia by Polygonum tinctorium Lour. J Nat Med. 54:261–264. 2000.
10	Imai T, Takakuwa R, Marchand S, Dentz E, Bornert JM, Messaddeq N, Wendling O, Mark M, Desvergne B, Wahli W, et al: Peroxisome proliferator-activated receptor γ is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci USA. 101:4543–4547. 2004. View Article : Google Scholar : PubMed/NCBI
11	Mauvais-Jarvis F, Clegg DJ and Hevener AL: The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 34:309–338. 2013. View Article : Google Scholar : PubMed/NCBI
12	Bolden A, Bernard L, Jones D, Akinyeke T and Stewart LV: The PPAR gamma agonist troglitazone regulates Erk ½ Phosphorylation via a PPARγ-Independent, MEK-dependent pathway in human prostate cancer cells. PPAR Res. 2012:9290522012. View Article : Google Scholar : PubMed/NCBI
13	Lebrasseur NK, Kelly M, Tsao T, Farmer SR, Saha AK, Ruderman NB and Tomas E: Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. Am J Physiol Endocrinol Metab. 291:E175–E181. 2006. View Article : Google Scholar : PubMed/NCBI
14	Slca T and Lucia M: SLC2A4 gene: A promising target for pharmacogenomics of insulin resistance E ditorial. Pharmacogenomics. 14:847–850. 2013. View Article : Google Scholar : PubMed/NCBI
15	Kudo M, Sugawara A, Uruno A, Takeuchi K and Ito S: Transcription suppression of peroxisome proliferator-activated receptor γ2 gene expression by tumor necrosis factor α via an inhibition of CCAAT/enhancer-binding protein δ during the early stage of adipocyte differentiation. Endocrinology. 145:4948–4956. 2004. View Article : Google Scholar : PubMed/NCBI
16	Marrow B, Secreted S and Protect C: Vitamin B12 as a modulator of gut microbial ecology. Cell Metab. 71:3831–3840. 2014.
17	Paar M, Jüngst C, Steiner NA, Magnes C, Sinner F, Kolb D, Lass A, Zimmermann R, Zumbusch A, Kohlwein SD and Wolinski H: Remodeling of lipid droplets during lipolysis and growth in adipocytes. J Biol Chem. 287:11164–11173. 2012. View Article : Google Scholar : PubMed/NCBI
18	Sharma G, Mauvais-Jarvis F and Prossnitz ER: Roles of G protein-coupled estrogen receptor GPER in metabolic regulation. J Steroid Biochem Mol Biol. 176:31–37. 2018. View Article : Google Scholar : PubMed/NCBI
19	Bost F, Aouadi M, Caron L and Binétruy B: The role of MAPKs in adipocyte differentiation and obesity. Biochimie. 87:51–56. 2005. View Article : Google Scholar : PubMed/NCBI
20	Burns KA and Vanden Heuvel JP: Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta. 1771:952–960. 2007. View Article : Google Scholar : PubMed/NCBI
21	Balakrishnan BB, Krishnasamy K and Choon K: Moringa concanensis Nimmo ameliorates hyperglycemia in 3T3-L1 adipocytes by upregulating PPAR-γ, C/EBP-α via Akt signaling pathway and STZ-induced diabetic rats. Biomed Pharmacother. 103:719–728. 2018. View Article : Google Scholar : PubMed/NCBI
22	Choe WK, Kang BT and Kim SO: Attenuates adipogenesis in murine 3T3-L1 adipocyte cells through the PI3K/Akt signaling pathway. Exp Ther Med. 1608–1615. 2018.PubMed/NCBI